Kaan Birgül

Kaan Birgül

Auto-generated profile, based on publicly available information

Kaan Birgül

University of Chemistry and Technology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KBKaan Birgül
Kaan Birgül
YYYeliz Yıldırım
Yeliz Yıldırım
HKHatice Yeşim Karasulu
Hatice Yeşim Karasulu
EKErcüment Karasulu
Ercüment Karasulu
AUAbdullahi Ibrahim Uba
Abdullahi Ibrahim Uba
SKS. Guniz Kucukguzel
S. Guniz Kucukguzel

1 July 2019 in Bioorganic Chemistry
Verified
Journal Article
Closed access
ATAslı Türe
Aslı Türe
NKNecla Kulabaş
Necla Kulabaş
SDSerap İpek Dingiş
Serap İpek Dingiş
KBKaan Birgül
Kaan Birgül
ABArif Bozdeveci
Arif Bozdeveci
İKİlkay Küçükgüzel
İlkay Küçükgüzel

10 November 2022 in Chirality
Verified
Journal Article
Closed access
CKCem Kaya
Cem Kaya
KBKaan Birgül
Kaan Birgül
BBBahadır Bülbül
Bahadır Bülbül

3 March 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
KBKaan Birgül
Kaan Birgül
AUAbdullahi Ibrahim Uba
Abdullahi Ibrahim Uba
OÇOzan Çuhadar
Ozan Çuhadar
SSSevgi Kocyigit Sevinc
Sevgi Kocyigit Sevinc
STSelen Tiryaki
Selen Tiryaki
SKS. Guniz Kucukguzel
S. Guniz Kucukguzel

22 March 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
MHMUHAMMED İHSAN HAN
MUHAMMED İHSAN HAN
UIUfuk İnCe
Ufuk İnCe
MGMiyase Gözde Gündüz
Miyase Gözde Gündüz
GCG. Pelin Coşkun
G. Pelin Coşkun
KBKaan Birgül
Kaan Birgül
SKS. Guniz Kucukguzel
S. Guniz Kucukguzel

22 October 2023 in Macromolecular Bioscience
Verified
Journal Article
Open access
SGSevgi Gülyüz
Sevgi Gülyüz
Melike SessevmezMelike Sessevmez
Melike Sessevmez
GUGokcen Ukuser
Gokcen Ukuser
MKMelek Parlak Khalily
Melek Parlak Khalily
STSelen Tiryaki
Selen Tiryaki
OYOzgur Yılmaz
Ozgur Yılmaz
This study focuses on creating a specialized nanogel for targeted drug delivery in cancer treatment, specifically targeting prostate cancer. This nanogel (referred to as SGK 636/Peptide 563/PEtOx nanogel) is created using hydrophilic poly(2‐ethyl‐2‐oxazoline) (PEtOx) through a combination of living/cationic ring‐opening polymerization (CROP) and alkyne‐azide cycloaddition (CuAAC) “click” chemical reactions. A fluorescent probe (BODIPY) is also conjugated with the nanogel to monitor drug delivery. The characterizations through 1H‐NMR, and FT‐IR, SEM, TEM, and DLS confirm the successful production of uniform, and spherical nanogels with controllable sizes (100 to 296 nm) and stability in physiological conditions. The biocompatibility of nanogels is evaluated using MTT cytotoxicity assays, revealing dose‐dependent cytotoxicity. Drug‐loaded nanogels exhibited significantly higher cytotoxicity against cancer cells in vitro compared to drug‐free nanogels. Targeting efficiency is examined using both peptide‐conjugated and peptide‐free nanogels, with the intracellular uptake of peptide 563‐conjugated nanogels by tumor cells being 60‐fold higher than that of nanogels without the peptide. The findings suggest that the prepared nanogel holds great potential for various drug delivery applications due to its ease of synthesis, tunable functionality, non‐toxicity, and enhanced intracellular uptake in the tumor region.